[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Matsumoto
K
K
Nagatake
T
T
D015310:Cefotiam / Q000008:administration & dosage; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D006020:Glycopeptides / Q000008:administration & dosage; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D016106:Methicillin Resistance; D008911:Minocycline / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects*; D017334:Teicoplanin; D014640:Vancomycin / Q000008:administration & dosage
D006020:Glycopeptides; D017334:Teicoplanin; D014640:Vancomycin; D015378:Imipenem; D015310:Cefotiam; D008911:Minocycline; D012293:Rifampin